Contrasting serum biomarker profiles in two Colombian populations with different risks for progression of premalignant gastric lesions during chronic Helicobacter pylori infection

•Coastal Colombians have lower Helicobacter pylori-associated gastric cancer compared to the Andes despite comparable infection and gastritis.•Lesion progression was associated with significant odds ratios for serum IL-5, trefoil factor 3 (TFF3), and low pepsinogen I/II ratio.•Low risk patients had...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancer epidemiology 2020-08, Vol.67, p.101726-101726, Article 101726
Hauptverfasser: Whary, Mark T., Avenia, Jose M. Restrepo, Bravo, Luis E., Lofgren, Jennifer L., Lertpiriyapong, Kvin, Mera-Giler, Robertino, Piazuelo, M. Blanca, Correa, Pelayo, Peek, Richard M., Wilson, Keith T., Fox, James G.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 101726
container_issue
container_start_page 101726
container_title Cancer epidemiology
container_volume 67
creator Whary, Mark T.
Avenia, Jose M. Restrepo
Bravo, Luis E.
Lofgren, Jennifer L.
Lertpiriyapong, Kvin
Mera-Giler, Robertino
Piazuelo, M. Blanca
Correa, Pelayo
Peek, Richard M.
Wilson, Keith T.
Fox, James G.
description •Coastal Colombians have lower Helicobacter pylori-associated gastric cancer compared to the Andes despite comparable infection and gastritis.•Lesion progression was associated with significant odds ratios for serum IL-5, trefoil factor 3 (TFF3), and low pepsinogen I/II ratio.•Low risk patients had elevated serum inflammatory biomarkers that reflect higher exposure to infectious diseases beyond H. pylori.•Data suggest IL-5, TFF3 and pepsinogen I/II ratios should be evaluated in combination to predict aggressive gastric histology. Colombians in coastal Tumaco have a lower incidence of Helicobacter pylori-associated gastric cancer compared to individuals from Tuquerres in the high Andes. This is despite nearly universal prevalence of H. pylori infection and chronic gastritis. H. pylori infection was confirmed by Steiner stain and serology using African and European-origin strains. Gastric histology and serum inflammatory biomarkers in dyspeptic Tumaco or Tuquerres patients were evaluated to predict progression of gastric lesions. H. pylori infection was nearly universal by Steiner stain and serology. IgG response to European-origin H. pylori strains were greater than African-origin. High gastric cancer-risk Tuquerres patients, compared to low-risk Tumaco, had significant odds ratios for lesion progression associated with serum IL-5, trefoil factor 3 (TFF3), and low pepsinogen I/II ratio. Sensitivity and specificity for these parameters was 63.8% and 67.9%, respectively, with correctly classifying patients at 66.7%. Most odds ratios for 26 other biomarkers were significant for the town of residency, indicating an environmental impact on Tumaco patients associated with decreased lesion progression. An IL-5 association with progression of gastric lesions is novel and could be evaluated in addition to TFF3 and pepsinogen I/II ratio as a non-invasive prognostic screen. Results suggest Tumaco patients were exposed to infectious diseases beyond H. pylori such as the documented high incidence of helminthiasis and toxoplasmosis. Results support a prior recommendation to evaluate TFF3 and pepsinogen I/II together to predict aggressive gastric histology. Our data indicate IL-5 should be further evaluated as prognostic parameter.
doi_str_mv 10.1016/j.canep.2020.101726
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7755565</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1877782120300606</els_id><sourcerecordid>2425586865</sourcerecordid><originalsourceid>FETCH-LOGICAL-c487t-60c29872f99c7970de4c8819b9b2f0eb6d43057cfd543980d99a6249f023f13b3</originalsourceid><addsrcrecordid>eNp9Uk1v1DAUjBCIlsIvQEKWuHDZxXE-HB9AqlZAkSpxAYmb5TjP2bd17GAnrfq7-IM42bICDpxsP8-bNx5Plr3M6Tanef32sNXKwbhllK0VzupH2XnecL7hTfH98WnP8rPsWYwHSus6z6un2VnBypKzkp1nP3feTUHFCV1PIoR5IC36QYUbCGQM3qCFSNCR6c6Tnbd-aFE5MvpxtmpC7yK5w2lPOjQGAriJBIw3kRi_tvcBYkwo4k06wqAs9k4lVJ9GBtQksa8k3RwWBXofvEvlK7Cofav0tMi4tz5gEmFALyOfZ0-MshFePKwX2bePH77urjbXXz593l1eb3TZ8GlTU81Ew5kRQnPBaQelbppctKJlhkJbd2VBK65NV5WFaGgnhKpZKQxlhcmLtrjI3h95x7kdoNOwOGXlGDD5cy-9Qvn3jcO97P2t5LyqqrpKBG8eCIL_MUOc5IBRg7Xp3_wcJStpXXFGqUjQ1_9AD34OLj0voVhVNXWzEhZHlA4-xgDmJCancgmFPMg1FHIJhTyGInW9-vMdp57fKUiAd0cAJDdvEYKMGsFp6DAky2Xn8b8DfgFt5c9s</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2425586865</pqid></control><display><type>article</type><title>Contrasting serum biomarker profiles in two Colombian populations with different risks for progression of premalignant gastric lesions during chronic Helicobacter pylori infection</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><source>ProQuest Central UK/Ireland</source><creator>Whary, Mark T. ; Avenia, Jose M. Restrepo ; Bravo, Luis E. ; Lofgren, Jennifer L. ; Lertpiriyapong, Kvin ; Mera-Giler, Robertino ; Piazuelo, M. Blanca ; Correa, Pelayo ; Peek, Richard M. ; Wilson, Keith T. ; Fox, James G.</creator><creatorcontrib>Whary, Mark T. ; Avenia, Jose M. Restrepo ; Bravo, Luis E. ; Lofgren, Jennifer L. ; Lertpiriyapong, Kvin ; Mera-Giler, Robertino ; Piazuelo, M. Blanca ; Correa, Pelayo ; Peek, Richard M. ; Wilson, Keith T. ; Fox, James G.</creatorcontrib><description>•Coastal Colombians have lower Helicobacter pylori-associated gastric cancer compared to the Andes despite comparable infection and gastritis.•Lesion progression was associated with significant odds ratios for serum IL-5, trefoil factor 3 (TFF3), and low pepsinogen I/II ratio.•Low risk patients had elevated serum inflammatory biomarkers that reflect higher exposure to infectious diseases beyond H. pylori.•Data suggest IL-5, TFF3 and pepsinogen I/II ratios should be evaluated in combination to predict aggressive gastric histology. Colombians in coastal Tumaco have a lower incidence of Helicobacter pylori-associated gastric cancer compared to individuals from Tuquerres in the high Andes. This is despite nearly universal prevalence of H. pylori infection and chronic gastritis. H. pylori infection was confirmed by Steiner stain and serology using African and European-origin strains. Gastric histology and serum inflammatory biomarkers in dyspeptic Tumaco or Tuquerres patients were evaluated to predict progression of gastric lesions. H. pylori infection was nearly universal by Steiner stain and serology. IgG response to European-origin H. pylori strains were greater than African-origin. High gastric cancer-risk Tuquerres patients, compared to low-risk Tumaco, had significant odds ratios for lesion progression associated with serum IL-5, trefoil factor 3 (TFF3), and low pepsinogen I/II ratio. Sensitivity and specificity for these parameters was 63.8% and 67.9%, respectively, with correctly classifying patients at 66.7%. Most odds ratios for 26 other biomarkers were significant for the town of residency, indicating an environmental impact on Tumaco patients associated with decreased lesion progression. An IL-5 association with progression of gastric lesions is novel and could be evaluated in addition to TFF3 and pepsinogen I/II ratio as a non-invasive prognostic screen. Results suggest Tumaco patients were exposed to infectious diseases beyond H. pylori such as the documented high incidence of helminthiasis and toxoplasmosis. Results support a prior recommendation to evaluate TFF3 and pepsinogen I/II together to predict aggressive gastric histology. Our data indicate IL-5 should be further evaluated as prognostic parameter.</description><identifier>ISSN: 1877-7821</identifier><identifier>EISSN: 1877-783X</identifier><identifier>DOI: 10.1016/j.canep.2020.101726</identifier><identifier>PMID: 32447242</identifier><language>eng</language><publisher>Netherlands: Elsevier Ltd</publisher><subject>Adult ; Biomarkers ; Biomarkers - blood ; Biopsy ; Cancer ; Case-Control Studies ; Chemokines ; Chronic infection ; Colombia ; Colombia - epidemiology ; Cytokines ; Environmental impact ; Epidemiology ; Evaluation ; Female ; Gastric cancer ; Gastritis ; Health risks ; Helicobacter Infections - complications ; Helicobacter Infections - virology ; Helicobacter pylori ; Helicobacter pylori - isolation &amp; purification ; Helminthiasis ; Histology ; Histopathology ; Humans ; Immunoglobulin G ; Incidence ; Infections ; Infectious diseases ; Inflammation ; Interleukin 5 ; Interleukin-5 - blood ; Lesions ; Male ; Middle Aged ; Parameter sensitivity ; Precancerous Conditions - blood ; Precancerous Conditions - epidemiology ; Precancerous Conditions - pathology ; Precancerous Conditions - virology ; Serology ; Serum biomarkers ; Stomach Neoplasms - blood ; Stomach Neoplasms - epidemiology ; Stomach Neoplasms - pathology ; Stomach Neoplasms - virology ; Toxoplasmosis ; Trefoil factor ; Trefoil Factor-3 - blood</subject><ispartof>Cancer epidemiology, 2020-08, Vol.67, p.101726-101726, Article 101726</ispartof><rights>2020</rights><rights>Copyright © 2020. Published by Elsevier Ltd.</rights><rights>Copyright Elsevier Limited Aug 2020</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c487t-60c29872f99c7970de4c8819b9b2f0eb6d43057cfd543980d99a6249f023f13b3</citedby><cites>FETCH-LOGICAL-c487t-60c29872f99c7970de4c8819b9b2f0eb6d43057cfd543980d99a6249f023f13b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/2425586865?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>230,314,780,784,885,3550,27924,27925,45995,64385,64387,64389,72469</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32447242$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Whary, Mark T.</creatorcontrib><creatorcontrib>Avenia, Jose M. Restrepo</creatorcontrib><creatorcontrib>Bravo, Luis E.</creatorcontrib><creatorcontrib>Lofgren, Jennifer L.</creatorcontrib><creatorcontrib>Lertpiriyapong, Kvin</creatorcontrib><creatorcontrib>Mera-Giler, Robertino</creatorcontrib><creatorcontrib>Piazuelo, M. Blanca</creatorcontrib><creatorcontrib>Correa, Pelayo</creatorcontrib><creatorcontrib>Peek, Richard M.</creatorcontrib><creatorcontrib>Wilson, Keith T.</creatorcontrib><creatorcontrib>Fox, James G.</creatorcontrib><title>Contrasting serum biomarker profiles in two Colombian populations with different risks for progression of premalignant gastric lesions during chronic Helicobacter pylori infection</title><title>Cancer epidemiology</title><addtitle>Cancer Epidemiol</addtitle><description>•Coastal Colombians have lower Helicobacter pylori-associated gastric cancer compared to the Andes despite comparable infection and gastritis.•Lesion progression was associated with significant odds ratios for serum IL-5, trefoil factor 3 (TFF3), and low pepsinogen I/II ratio.•Low risk patients had elevated serum inflammatory biomarkers that reflect higher exposure to infectious diseases beyond H. pylori.•Data suggest IL-5, TFF3 and pepsinogen I/II ratios should be evaluated in combination to predict aggressive gastric histology. Colombians in coastal Tumaco have a lower incidence of Helicobacter pylori-associated gastric cancer compared to individuals from Tuquerres in the high Andes. This is despite nearly universal prevalence of H. pylori infection and chronic gastritis. H. pylori infection was confirmed by Steiner stain and serology using African and European-origin strains. Gastric histology and serum inflammatory biomarkers in dyspeptic Tumaco or Tuquerres patients were evaluated to predict progression of gastric lesions. H. pylori infection was nearly universal by Steiner stain and serology. IgG response to European-origin H. pylori strains were greater than African-origin. High gastric cancer-risk Tuquerres patients, compared to low-risk Tumaco, had significant odds ratios for lesion progression associated with serum IL-5, trefoil factor 3 (TFF3), and low pepsinogen I/II ratio. Sensitivity and specificity for these parameters was 63.8% and 67.9%, respectively, with correctly classifying patients at 66.7%. Most odds ratios for 26 other biomarkers were significant for the town of residency, indicating an environmental impact on Tumaco patients associated with decreased lesion progression. An IL-5 association with progression of gastric lesions is novel and could be evaluated in addition to TFF3 and pepsinogen I/II ratio as a non-invasive prognostic screen. Results suggest Tumaco patients were exposed to infectious diseases beyond H. pylori such as the documented high incidence of helminthiasis and toxoplasmosis. Results support a prior recommendation to evaluate TFF3 and pepsinogen I/II together to predict aggressive gastric histology. Our data indicate IL-5 should be further evaluated as prognostic parameter.</description><subject>Adult</subject><subject>Biomarkers</subject><subject>Biomarkers - blood</subject><subject>Biopsy</subject><subject>Cancer</subject><subject>Case-Control Studies</subject><subject>Chemokines</subject><subject>Chronic infection</subject><subject>Colombia</subject><subject>Colombia - epidemiology</subject><subject>Cytokines</subject><subject>Environmental impact</subject><subject>Epidemiology</subject><subject>Evaluation</subject><subject>Female</subject><subject>Gastric cancer</subject><subject>Gastritis</subject><subject>Health risks</subject><subject>Helicobacter Infections - complications</subject><subject>Helicobacter Infections - virology</subject><subject>Helicobacter pylori</subject><subject>Helicobacter pylori - isolation &amp; purification</subject><subject>Helminthiasis</subject><subject>Histology</subject><subject>Histopathology</subject><subject>Humans</subject><subject>Immunoglobulin G</subject><subject>Incidence</subject><subject>Infections</subject><subject>Infectious diseases</subject><subject>Inflammation</subject><subject>Interleukin 5</subject><subject>Interleukin-5 - blood</subject><subject>Lesions</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Parameter sensitivity</subject><subject>Precancerous Conditions - blood</subject><subject>Precancerous Conditions - epidemiology</subject><subject>Precancerous Conditions - pathology</subject><subject>Precancerous Conditions - virology</subject><subject>Serology</subject><subject>Serum biomarkers</subject><subject>Stomach Neoplasms - blood</subject><subject>Stomach Neoplasms - epidemiology</subject><subject>Stomach Neoplasms - pathology</subject><subject>Stomach Neoplasms - virology</subject><subject>Toxoplasmosis</subject><subject>Trefoil factor</subject><subject>Trefoil Factor-3 - blood</subject><issn>1877-7821</issn><issn>1877-783X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNp9Uk1v1DAUjBCIlsIvQEKWuHDZxXE-HB9AqlZAkSpxAYmb5TjP2bd17GAnrfq7-IM42bICDpxsP8-bNx5Plr3M6Tanef32sNXKwbhllK0VzupH2XnecL7hTfH98WnP8rPsWYwHSus6z6un2VnBypKzkp1nP3feTUHFCV1PIoR5IC36QYUbCGQM3qCFSNCR6c6Tnbd-aFE5MvpxtmpC7yK5w2lPOjQGAriJBIw3kRi_tvcBYkwo4k06wqAs9k4lVJ9GBtQksa8k3RwWBXofvEvlK7Cofav0tMi4tz5gEmFALyOfZ0-MshFePKwX2bePH77urjbXXz593l1eb3TZ8GlTU81Ew5kRQnPBaQelbppctKJlhkJbd2VBK65NV5WFaGgnhKpZKQxlhcmLtrjI3h95x7kdoNOwOGXlGDD5cy-9Qvn3jcO97P2t5LyqqrpKBG8eCIL_MUOc5IBRg7Xp3_wcJStpXXFGqUjQ1_9AD34OLj0voVhVNXWzEhZHlA4-xgDmJCancgmFPMg1FHIJhTyGInW9-vMdp57fKUiAd0cAJDdvEYKMGsFp6DAky2Xn8b8DfgFt5c9s</recordid><startdate>20200801</startdate><enddate>20200801</enddate><creator>Whary, Mark T.</creator><creator>Avenia, Jose M. Restrepo</creator><creator>Bravo, Luis E.</creator><creator>Lofgren, Jennifer L.</creator><creator>Lertpiriyapong, Kvin</creator><creator>Mera-Giler, Robertino</creator><creator>Piazuelo, M. Blanca</creator><creator>Correa, Pelayo</creator><creator>Peek, Richard M.</creator><creator>Wilson, Keith T.</creator><creator>Fox, James G.</creator><general>Elsevier Ltd</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7TO</scope><scope>7X7</scope><scope>7XB</scope><scope>88C</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20200801</creationdate><title>Contrasting serum biomarker profiles in two Colombian populations with different risks for progression of premalignant gastric lesions during chronic Helicobacter pylori infection</title><author>Whary, Mark T. ; Avenia, Jose M. Restrepo ; Bravo, Luis E. ; Lofgren, Jennifer L. ; Lertpiriyapong, Kvin ; Mera-Giler, Robertino ; Piazuelo, M. Blanca ; Correa, Pelayo ; Peek, Richard M. ; Wilson, Keith T. ; Fox, James G.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c487t-60c29872f99c7970de4c8819b9b2f0eb6d43057cfd543980d99a6249f023f13b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Adult</topic><topic>Biomarkers</topic><topic>Biomarkers - blood</topic><topic>Biopsy</topic><topic>Cancer</topic><topic>Case-Control Studies</topic><topic>Chemokines</topic><topic>Chronic infection</topic><topic>Colombia</topic><topic>Colombia - epidemiology</topic><topic>Cytokines</topic><topic>Environmental impact</topic><topic>Epidemiology</topic><topic>Evaluation</topic><topic>Female</topic><topic>Gastric cancer</topic><topic>Gastritis</topic><topic>Health risks</topic><topic>Helicobacter Infections - complications</topic><topic>Helicobacter Infections - virology</topic><topic>Helicobacter pylori</topic><topic>Helicobacter pylori - isolation &amp; purification</topic><topic>Helminthiasis</topic><topic>Histology</topic><topic>Histopathology</topic><topic>Humans</topic><topic>Immunoglobulin G</topic><topic>Incidence</topic><topic>Infections</topic><topic>Infectious diseases</topic><topic>Inflammation</topic><topic>Interleukin 5</topic><topic>Interleukin-5 - blood</topic><topic>Lesions</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Parameter sensitivity</topic><topic>Precancerous Conditions - blood</topic><topic>Precancerous Conditions - epidemiology</topic><topic>Precancerous Conditions - pathology</topic><topic>Precancerous Conditions - virology</topic><topic>Serology</topic><topic>Serum biomarkers</topic><topic>Stomach Neoplasms - blood</topic><topic>Stomach Neoplasms - epidemiology</topic><topic>Stomach Neoplasms - pathology</topic><topic>Stomach Neoplasms - virology</topic><topic>Toxoplasmosis</topic><topic>Trefoil factor</topic><topic>Trefoil Factor-3 - blood</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Whary, Mark T.</creatorcontrib><creatorcontrib>Avenia, Jose M. Restrepo</creatorcontrib><creatorcontrib>Bravo, Luis E.</creatorcontrib><creatorcontrib>Lofgren, Jennifer L.</creatorcontrib><creatorcontrib>Lertpiriyapong, Kvin</creatorcontrib><creatorcontrib>Mera-Giler, Robertino</creatorcontrib><creatorcontrib>Piazuelo, M. Blanca</creatorcontrib><creatorcontrib>Correa, Pelayo</creatorcontrib><creatorcontrib>Peek, Richard M.</creatorcontrib><creatorcontrib>Wilson, Keith T.</creatorcontrib><creatorcontrib>Fox, James G.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Cancer epidemiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Whary, Mark T.</au><au>Avenia, Jose M. Restrepo</au><au>Bravo, Luis E.</au><au>Lofgren, Jennifer L.</au><au>Lertpiriyapong, Kvin</au><au>Mera-Giler, Robertino</au><au>Piazuelo, M. Blanca</au><au>Correa, Pelayo</au><au>Peek, Richard M.</au><au>Wilson, Keith T.</au><au>Fox, James G.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Contrasting serum biomarker profiles in two Colombian populations with different risks for progression of premalignant gastric lesions during chronic Helicobacter pylori infection</atitle><jtitle>Cancer epidemiology</jtitle><addtitle>Cancer Epidemiol</addtitle><date>2020-08-01</date><risdate>2020</risdate><volume>67</volume><spage>101726</spage><epage>101726</epage><pages>101726-101726</pages><artnum>101726</artnum><issn>1877-7821</issn><eissn>1877-783X</eissn><abstract>•Coastal Colombians have lower Helicobacter pylori-associated gastric cancer compared to the Andes despite comparable infection and gastritis.•Lesion progression was associated with significant odds ratios for serum IL-5, trefoil factor 3 (TFF3), and low pepsinogen I/II ratio.•Low risk patients had elevated serum inflammatory biomarkers that reflect higher exposure to infectious diseases beyond H. pylori.•Data suggest IL-5, TFF3 and pepsinogen I/II ratios should be evaluated in combination to predict aggressive gastric histology. Colombians in coastal Tumaco have a lower incidence of Helicobacter pylori-associated gastric cancer compared to individuals from Tuquerres in the high Andes. This is despite nearly universal prevalence of H. pylori infection and chronic gastritis. H. pylori infection was confirmed by Steiner stain and serology using African and European-origin strains. Gastric histology and serum inflammatory biomarkers in dyspeptic Tumaco or Tuquerres patients were evaluated to predict progression of gastric lesions. H. pylori infection was nearly universal by Steiner stain and serology. IgG response to European-origin H. pylori strains were greater than African-origin. High gastric cancer-risk Tuquerres patients, compared to low-risk Tumaco, had significant odds ratios for lesion progression associated with serum IL-5, trefoil factor 3 (TFF3), and low pepsinogen I/II ratio. Sensitivity and specificity for these parameters was 63.8% and 67.9%, respectively, with correctly classifying patients at 66.7%. Most odds ratios for 26 other biomarkers were significant for the town of residency, indicating an environmental impact on Tumaco patients associated with decreased lesion progression. An IL-5 association with progression of gastric lesions is novel and could be evaluated in addition to TFF3 and pepsinogen I/II ratio as a non-invasive prognostic screen. Results suggest Tumaco patients were exposed to infectious diseases beyond H. pylori such as the documented high incidence of helminthiasis and toxoplasmosis. Results support a prior recommendation to evaluate TFF3 and pepsinogen I/II together to predict aggressive gastric histology. Our data indicate IL-5 should be further evaluated as prognostic parameter.</abstract><cop>Netherlands</cop><pub>Elsevier Ltd</pub><pmid>32447242</pmid><doi>10.1016/j.canep.2020.101726</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1877-7821
ispartof Cancer epidemiology, 2020-08, Vol.67, p.101726-101726, Article 101726
issn 1877-7821
1877-783X
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7755565
source MEDLINE; Access via ScienceDirect (Elsevier); ProQuest Central UK/Ireland
subjects Adult
Biomarkers
Biomarkers - blood
Biopsy
Cancer
Case-Control Studies
Chemokines
Chronic infection
Colombia
Colombia - epidemiology
Cytokines
Environmental impact
Epidemiology
Evaluation
Female
Gastric cancer
Gastritis
Health risks
Helicobacter Infections - complications
Helicobacter Infections - virology
Helicobacter pylori
Helicobacter pylori - isolation & purification
Helminthiasis
Histology
Histopathology
Humans
Immunoglobulin G
Incidence
Infections
Infectious diseases
Inflammation
Interleukin 5
Interleukin-5 - blood
Lesions
Male
Middle Aged
Parameter sensitivity
Precancerous Conditions - blood
Precancerous Conditions - epidemiology
Precancerous Conditions - pathology
Precancerous Conditions - virology
Serology
Serum biomarkers
Stomach Neoplasms - blood
Stomach Neoplasms - epidemiology
Stomach Neoplasms - pathology
Stomach Neoplasms - virology
Toxoplasmosis
Trefoil factor
Trefoil Factor-3 - blood
title Contrasting serum biomarker profiles in two Colombian populations with different risks for progression of premalignant gastric lesions during chronic Helicobacter pylori infection
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T15%3A32%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Contrasting%20serum%20biomarker%20profiles%20in%20two%20Colombian%20populations%20with%20different%20risks%20for%20progression%20of%20premalignant%20gastric%20lesions%20during%20chronic%20Helicobacter%20pylori%20infection&rft.jtitle=Cancer%20epidemiology&rft.au=Whary,%20Mark%20T.&rft.date=2020-08-01&rft.volume=67&rft.spage=101726&rft.epage=101726&rft.pages=101726-101726&rft.artnum=101726&rft.issn=1877-7821&rft.eissn=1877-783X&rft_id=info:doi/10.1016/j.canep.2020.101726&rft_dat=%3Cproquest_pubme%3E2425586865%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2425586865&rft_id=info:pmid/32447242&rft_els_id=S1877782120300606&rfr_iscdi=true